Form 4: Molina Healthcare Director Receives Equity Grant
Insider Transaction Report
Molina Healthcare Director Barbara L. Brasier received a grant of 317 shares of common stock valued at $173.54 per share as part of her director compensation plan.
Summary
- Barbara L. Brasier, a Director of Molina Healthcare, Inc. (MOH), acquired 317 shares of common stock.
- The transaction occurred on January 1, 2026, and was made pursuant to a Rule 10b5-1 plan.
- The shares were granted under the Issuer's 2025 Equity Incentive Plan for services as a Director.
- The grant value was calculated based on the closing price of $173.54 per share on December 31, 2025, as January 1, 2026, was a non-trading day.
- This grant represents one quarter of an annual equity award, with the aggregate annual award set at $220,000, meaning this quarterly grant was valued at $55,000.
- Following this transaction, Barbara L. Brasier beneficially owns 5,176 shares of Molina Healthcare common stock directly.
Sentiment
Score: 6
Explanation: The filing reports a routine, pre-planned equity grant to a director, which is a neutral to slightly positive event as it increases director ownership and aligns interests with shareholders, without indicating any new operational or financial performance information.
Positives
- Director Barbara L. Brasier increased her direct beneficial ownership in Molina Healthcare by 317 shares, aligning her interests further with shareholders.
- The equity grant is part of a structured 2025 Equity Incentive Plan, indicating a clear and pre-approved compensation strategy for directors.
Future Outlook
The filing indicates a structured approach to director compensation through the 2025 Equity Incentive Plan, with quarterly grants expected to continue based on the aggregate annual award of $220,000.
Industry Context
This transaction represents a routine equity grant to a director, which is a common practice across publicly traded companies in the healthcare sector and broader market. Such grants are typically part of a director's compensation package, designed to align their interests with those of shareholders.
Comparison to Industry Standards
- The grant of equity as part of director compensation is a standard practice in corporate governance across U.S. public companies, including those in the healthcare industry.
- The use of a Rule 10b5-1 plan for the transaction is also a common mechanism for insiders to manage stock transactions in compliance with SEC regulations, demonstrating adherence to best practices.
- While specific comparable companies or projects are not detailed in the filing, the structure of an annual equity award distributed quarterly is a widely adopted model for director remuneration, aiming to provide ongoing alignment and retention.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | Grant of common stock under the Issuer's 2025 Equity Incentive Plan for director services, with an aggregate annual equity award of $220,000, distributed quarterly. | 2026-01-01 | Reinforces director alignment with shareholder interests through equity ownership. |
Related Party Transactions
- Director Barbara L. Brasier received a grant of 317 shares of common stock from Molina Healthcare, Inc. as part of her compensation for services, which is a standard related-party transaction under the company's 2025 Equity Incentive Plan.
Stakeholder Impact
- Shareholders: Positive impact due to increased alignment of a director's interests with shareholder value through equity ownership.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Next Steps
- Future quarterly equity grants to directors are anticipated as part of the ongoing 2025 Equity Incentive Plan.
Key Dates
| Date | Description |
|---|---|
| 2019-05-08 | Date of Limited Power of Attorney for Section 16(a) filings. |
| 2025-12-31 | Closing price of Molina Healthcare common stock used for grant calculation ($173.54 per share). |
| 2026-01-01 | Date of earliest transaction and stock grant to Director Barbara L. Brasier. |
| 2026-01-02 | Signature date of the Form 4 filing by power of attorney. |
Recommendation
holdThis Form 4 filing details a routine, pre-scheduled equity grant to a director as part of their compensation package. It does not contain any new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is a standard governance practice aimed at aligning director interests with shareholders.
Keywords
Molina Healthcare, MOH, Form 4, Insider Transaction, Stock Grant, Director Compensation, Equity Incentive Plan, Barbara L. Brasier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.